Assessing and Working with Patients with Cognitive Impairment and Dementia
Marc Agronin, MD
Geriatric Psychiatrist
Vice President, Behavioral Health and Clinical Research
Miami Jewish Health Systems, Miami, FL
Dr. Agronin has disclosed that he is principal investigator on research grants from several pharmaceutical firms and that all funds go directly to his employer, Miami Jewish Health Systems. In addition, he has been on the speakers bureaus of Forest Laboratories (Namenda XR), AssurX (GeneSightRX), and Novartis (Exelon Patch). Dr. Carlat has reviewed the content of the interview and has determined that there is no bias due to these relationships.
Read More
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
